Cellectis CLLS
NASDAQ CLLS
$3.24 -0.08 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Cellectis (CLLS) Inventory Average (2017 - 2021)

Cellectis (CLLS) posted quarterly Inventory Average of $2.1 million for Q3 2021, down 65.4% year-over-year from $6.0 million in Q3 2020, and down 46.78% quarter-over-quarter from $3.9 million in Q2 2021.

Analysis

Cellectis (CLLS) Inventory Average (2017 - 2021) Analysis & Trends

Cellectis' Inventory Average history runs 5 years deep, the most recent figure standing at $2.1 million for Q3 2021.

  • In Q3 2021, Inventory Average fell 65.4% year-over-year to $2.1 million; the TTM figure through Sep 2021 stood at $2.1 million (down 65.4% YoY), while the FY2020 annual figure was $2.2 million, up 41.77% from the prior year.
  • Inventory Average for Q3 2021 stood at $2.1 million, down from $3.9 million in the prior quarter.
  • The five-year high for Inventory Average was $6.0 million in Q3 2020, with the low at $116931.1 in Q1 2017.
  • The 5-year median for Inventory Average is $1.0 million (2019), against an average of $1.9 million.
  • The sharpest annual moves came in 2019 and 2021: Inventory Average soared 1153.21% in 2019, then sank 65.4% in 2021.
  • Cellectis' Inventory Average stood at $187500.0 in 2017, then jumped by 32.8% to $249000.0 in 2018, then jumped by 1153.21% to $3.1 million in 2019, then increased by 25.97% to $3.9 million in 2020, then tumbled by 47.32% to $2.1 million in 2021.
  • Business Quant data shows CLLS's Inventory Average at $2.1 million in Q3 2021, $3.9 million in Q2 2021, and $3.5 million in Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.77 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 3.09 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 213.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 707.10 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 90.57 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 137.65 Mn
10 Cellectis 321.90 Mn 155.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 2.07 Mn
Jun 30, 2021 3.89 Mn
Mar 31, 2021 3.46 Mn
Dec 31, 2020 3.93 Mn
Sep 30, 2020 5.99 Mn
Jun 30, 2020 4.65 Mn
Mar 31, 2020 3.24 Mn
Dec 31, 2019 3.12 Mn
Sep 30, 2019 2.17 Mn
Jun 30, 2019 1.02 Mn
Mar 31, 2019 664,500.00
Dec 31, 2018 249,000.00
Sep 30, 2018 227,000.00
Jun 30, 2018 217,000.00
Mar 31, 2018 226,500.00
Dec 31, 2017 187,500.00
Sep 30, 2017 125,174.31
Jun 30, 2017 119,140.88
Mar 31, 2017 116,931.12